ID   AT3B-1
AC   CVCL_3489
SY   AT3B1
DR   CLO; CLO_0001760
DR   ATCC; CRL-2375
DR   ChEMBL-Cells; CHEMBL3308085
DR   ChEMBL-Targets; CHEMBL613873
DR   PubChem_Cell_line; CVCL_3489
DR   Wikidata; Q54750914
RX   PubMed=9494564;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0146 ! R-3327-AT-3
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
RX   PubMed=9494564;
RA   Replogle-Schwab, Tracy S.
RA   Schwab, Eric D.
RA   Pienta, Kenneth James
RT   "Development of doxorubicin resistant rat prostate cancer cell
RT   lines.";
RL   Anticancer Res. 17:4535-4538(1997).
//